Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Obinutuzumab (Gazyva) 1000mg/40ml Sdv [Thay] (CDM 23563797) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 12, 2026 , from http://ppman.hank.ai/transparency/procedure/23563797/by-state?code_type=CDM
“Obinutuzumab (Gazyva) 1000mg/40ml Sdv [Thay] (CDM 23563797) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/23563797/by-state?code_type=CDM. Accessed
November 12, 2026 .
“Obinutuzumab (Gazyva) 1000mg/40ml Sdv [Thay] (CDM 23563797) by State,” HANK Price Transparency ,
accessed November 12, 2026 ,
http://ppman.hank.ai/transparency/procedure/23563797/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
23563797 — Obinutuzumab (Gazyva) 1000mg/40ml Sdv [Thay]
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$12,681
National median
$11,301 – $13,043
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 23563797 (CDM), with interquartile range
State Median p25 p75
NE $12,681 $11,301 $13,043